SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

 

 

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     Yes  ý  No  o

 

The number of shares of Common Stock, no par value, outstanding on May 9, 2002 was 16,102,441 shares.

 

 

NATURE’S SUNSHINE PRODUCTS, INC.

FORM 10-Q

 

For The Quarter Ended March 31, 2002

 

Table of Contents

 

Part I.	Financial Information
	Item 1.	Unaudited Financial Statements
		Condensed Consolidated Balance Sheets
		Condensed Consolidated Statements of Income
		Condensed Consolidated Statements of Cash Flows
		Notes to Condensed Consolidated Financial Statements
	Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations
	Item 3.	Quantitative and Qualitative Disclosures about Market Risk
Part II.	Other Information
	Item 6.	Exhibits and Reports on Form 8-K

 

2

 

PART I  FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

NATURE’S SUNSHINE PRODUCTS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Amounts In Thousands)

(Unaudited)

 

		March 31, 2002			December 31, 2001
ASSETS
CURRENT ASSETS:
Cash and cash equivalents		$	30,597		$	29,788
Accounts receivable, net		5,941			6,327
Inventories		27,523			26,834
Deferred income tax assets		1,864			1,188
Prepaid expenses and other		8,202			9,209
Total Current Assets		74,127			73,346
PROPERTY, PLANT AND EQUIPMENT, net		34,809			35,294
LONG-TERM INVESTMENTS		10,685			12,973
INTANGIBLE ASSETS, net		4,426			4,753
OTHER ASSETS, net		4,906			5,062
		$	128,953		$	131,428
LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES:
Accounts payable		$	5,069		$	4,814
Accrued volume incentives		11,150			12,005
Accrued liabilities		14,255			11,978
Income taxes payable		2,826			3,988
Total Current Liabilities		33,300			32,785
LONG-TERM LIABILITIES:
Deferred income tax liabilities		469			1,220
Deferred compensation		1,717			1,625
Total Long-Term Liabilities		2,186			2,845
SHAREHOLDERS’ EQUITY:
Common stock, no par value;  20,000 shares authorized, 19,446 shares issued		34,877			36,308
Retained earnings		115,407			116,836
Treasury stock, at cost, 3,209 and 3,180 shares, respectively		(42,964		)	(43,538		)
Accumulated other comprehensive loss		(13,853		)	(13,808		)
Total Shareholders’ Equity		93,467			95,798
		$	128,953		$	131,428

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

3

 

NATURE’S SUNSHINE PRODUCTS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

AND COMPREHENSIVE INCOME

(Amounts In Thousands, Except Per-Share Information)

(Unaudited)

 

		Three Months Ended March 31,
		2002			2001
SALES REVENUE		$	75,860		$	81,694
COSTS AND EXPENSES:
Cost of goods sold		13,615			14,613
Volume incentives		33,375			36,283
Selling, general and administrative		27,087			24,393
		74,077			75,289
OPERATING INCOME		1,783			6,405
OTHER EXPENSE
Impairment of investment		(3,000		)	—
Other income (expense), net		728			(41		)
		(2,272		)	(41		)
INCOME (LOSS) BEFORE PROVISION FOR INCOME TAXES		(489		)	6,364
PROVISION FOR INCOME TAXES		399			2,342
NET INCOME (LOSS)		(888		)	4,022
OTHER COMPREHENSIVE LOSS, net of tax:
Foreign currency translation adjustments		(930		)	(1,006		)
Net unrealized holding gains (losses) on marketable securities		(540		)	2
Reclassification adjustment for losses included in net income (loss)		1,425			—
		(45		)	(1,004		)
COMPREHENSIVE INCOME (LOSS)		$	(933	)	$	3,018
BASIC NET INCOME (LOSS) PER COMMON SHARE		$	(0.05	)	$	0.25
WEIGHTED AVERAGE BASIC COMMON SHARES		16,262			16,287
DILUTED NET INCOME (LOSS) PER COMMON SHARE		$	(0.05	)	$	0.25
WEIGHTED AVERAGE DILUTED COMMON SHARES		16,262			16,344

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

4

 

NATURE’S SUNSHINE PRODUCTS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

Increase (Decrease) in Cash and Cash Equivalents

(Amounts In Thousands)

(Unaudited)

 

		Three Months Ended March 31,
		2002			2001
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)		$	(888	)	$	4,002
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization		1,868			1,860
Tax benefit from stock option exercises		287			—
Loss on sale of property, plant and equipment		127			9
Deferred income taxes		(1,426		)	(9		)
Deferred compensation		91			57
Loss on impaired investment		3,000			—
Changes in assets and liabilities:
Accounts receivable, net		386			(581		)
Inventories		(689		)	854
Prepaid expenses and other assets		1,184			1,308
Accounts payable		255			(192		)
Accrued volume incentives		(855		)	2,634
Accrued liabilities		2,277			628
Income taxes payable		(1,161		)	(13		)
Cumulative currency translation adjustments		(786		)	(519		)
Net Cash Provided by Operating Activities		3,670			10,058
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures		(1,200		)	(3,274		)
Proceeds from (Purchase of) long-term investments, net		173			(51		)
Payments received (Advances) on long-term receivables		(22		)	91
Purchase of other assets		(20		)	(278		)
Proceeds from sale of property, plant and equipment		38			35
Net Cash Used in Investing Activities		(1,031		)	(3,477		)
CASH FLOWS FROM FINANCING ACTIVITIES:
Payment of cash dividends		(541		)	(542		)
Purchase of treasury stock		(2,137		)	(1,136		)
Repayments of short-term debt		—			(155		)
Proceeds from exercise of stock options		992			16
Net Cash Used in Financing Activities		(1,686		)	(1,817		)
EFFECT OF EXCHANGE RATES ON CASH		(144		)	(487		)
NET INCREASE IN CASH AND CASH EQUIVALENTS		809			4,277
CASH AND CASH EQUIVALENTS AT BEGINNING OF THE PERIOD		29,788			28,803
CASH AND CASH EQUIVALENTS AT END OF THE PERIOD		$	30,597		$	33,080

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

5

 

NATURE’S SUNSHINE PRODUCTS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts In Thousands, Except Per-Share Information)

(Unaudited)

 

(1)           INTERIM FINANCIAL STATEMENT POLICIES AND DISCLOSURES

 

The unaudited, condensed consolidated financial statements of Nature’s Sunshine Products, Inc. and subsidiaries included herein have been prepared pursuant to the rules and regulations of the United States Securities and Exchange Commission.  Certain information and footnote disclosures normally required in financial statements prepared in accordance with accounting principles generally accepted in the United States have been condensed or omitted pursuant to such rules and regulations, although the Company believes the following disclosures are adequate to make the information presented not misleading.

 

These condensed consolidated financial statements reflect all adjustments, which in the opinion of management are necessary to present fairly the financial position as of March 31, 2002, and the results of operations and cash flows for the periods presented.  All of the adjustments which have been made in these condensed consolidated financial statements are of a normal recurring nature.  Operating results for the three months ended March 31, 2002, are not necessarily indicative of the results that may be expected for the year ending December 31, 2002.

 

The Company suggests that these condensed consolidated financial statements be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2001.

 

(2)           RECENT ACCOUNTING PRONOUNCEMENTS

 

In July 2001, the Financial Accounting Standards Board issued Statement of Financial Accounting Standard (“SFAS”) No. 141, “Business Combinations”, and SFAS No. 142, “Goodwill and Other Intangible Assets.” SFAS No. 141 requires business combinations initiated after June 30, 2001, to be accounted for using the purchase method of accounting and broadens the criteria for recording identifiable intangible assets separate from goodwill and amounts previously recorded as goodwill may be separately identified and recognized apart from goodwill.  SFAS No. 142 requires the use of a nonamortization approach to account for goodwill and indefinite-lived intangibles, and instead these assets are reviewed for impairment on a periodic basis as appropriate. The provisions of each statement which apply to goodwill and intangible assets acquired prior to June 30, 2001, were adopted by the Company on January 1, 2002.

 

In connection with the adoption of SFAS No. 142, the Company reassessed the useful lives and classification of its intangible assets.  The Company determined that $3,213 of previously identified goodwill should be classified as an acquired distributor network and continue to be amortized over a 10-year

 

6

 

period. The Company has determined that none of its intangible assets are impaired.  Because all of the Company’s intangible assets continue to be amortized over the same useful lives, there is no impact on operations.  Therefore, no reconciliation of reported net income (loss) to adjusted net income (loss) is presented.  Information regarding the Company’s intangible assets is as follows:

 

		As of March 31, 2002									As of December 31, 2001
		Carrying Amount			Accumulated Amortization			Net			Carrying Amount			Accumulated Amortization			Net
Patents and Trademarks		$	1,202		$	888		$	314		$	1,202		$	829		$	373
Acquired Distributor Networks		5,634			1,891			3,743			5,634			1,674			3,960
Product Registrations		791			422			369			773			353			420
Total		$	7,627		$	3,201		$	4,426		$	7,609		$	2,356		$	4,753

 

Amortization expense for intangible assets for the three months ended March 31, 2002, was $345.  Estimated amortization expense for the remainder of 2002 and  the five succeeding  fiscal years follows:

 

 

(3)           INVENTORIES

 

Inventories consist of the following:

 

 

(4)           NET INCOME PER COMMON SHARE

 

Basic net income per common share (Basic EPS) excludes dilution and is computed by dividing net income by the weighted-average number of common shares outstanding during the period.  Diluted net  income per common  share (Diluted EPS) reflects the  potential dilution that  could  occur if stock options or other contracts to issue common stock were exercised or converted into common stock.  The computation of Diluted EPS does not assume exercise or conversion of securities that would have an anti-dilutive effect on net income per common share.

 

As of March 31, 2002, the Company had a total of 3,759 common stock options outstanding.  These options were all granted at fair market value and have a weighted-average exercise price of $8.17 per share.

 

7

 

Following is a reconciliation of the numerator and denominator of Basic EPS to the numerator and denominator of Diluted EPS for the three months ended March 31, 2002 and 2001:

 

		Net Income (Numerator)			Shares (Denominator)		Per Share Amount
Three Months Ended March 31, 2002
Basic EPS		$	(888	)	16,262		$	(0.05	)
Effect of stock options		—			—		—
Diluted EPS		$	(888	)	16,262		$	(0.05	)
Three Months Ended March 31, 2001
Basic EPS		$	4,022		16,287		$	0.25
Effect of stock options		—			57		—
Diluted EPS		$	4,022		16,344		$	0.25

 

For the three months ended March 31, 2002 and 2001, there were outstanding options to purchase 3,759 and 1,246 shares of common stock, respectively, that were not included in the computation of Diluted EPS, as their effect would have been anti-dilutive.

 

(5)           EQUITY TRANSACTIONS

 

The Company has declared consecutive quarterly cash dividends since 1988. The most recent quarterly cash dividend of 3 1/3 cents per common share was declared on April 30, 2002, to shareholders of record on May 14, 2002, and is payable on May 21, 2002.

 

For the three months ended March 31, 2002, the Company repurchased approximately 169 shares of its common stock at an average price per share of $12.66 as part of its 1,000-share buyback program authorized by the Company’s Board of Directors in February 2001.  As of May 9, 2002, the Company has approximately 555 shares remaining under the current buyback program.

 

(6)           ACCUMULATED OTHER COMPREHENSIVE LOSS

 

The composition of accumulated other comprehensive loss, net of tax, is as follows:

 

		Foreign Currency Adjustments			Unrealized Gains (Losses) on Available-for Sale Securities			Total Accumulated Other Comprehensive Loss
Balance as of December 31, 2001		$	(13,158	)	$	(650	)	$	(13,808	)
Current period change		(930		)	885			(45		)
Balance as of March 31, 2002		$	(14,088	)	$	235		$	(13,853	)

 

8

 

(7)           SEGMENT INFORMATION

 

The Company has four operating segments.  These operating segments are components of the Company for which separate information is available that is evaluated regularly by management in deciding how to allocate resources and assess performance.  The Company evaluates performance based on operating income (loss).

 

The Company’s operating segments are based on geographic operations.  Intersegment sales are eliminated in consolidation and are not material.

 

Operating segment information for the three months ended March 31, 2002 and 2001, is as follows:

 

		2002			2001
Sales Revenue:
United States		$	44,151		$	46,044
International:
Latin America		15,754			19,864
Asia Pacific		10,030			10,264
Other		5,925			5,522
		75,860			81,694
Operating Expenses:
United States		43,075			41,596
International:
Latin America		14,881			18,361
Asia Pacific		10,490			10,290
Other		5,631			5,042
		74,077			75,289
Operating Income:
United States		1,076			4,448
International:
Latin America		873			1,503
Asia Pacific		(460		)	(26		)
Other		294			480
		1,783			6,405
Other Income (Expense)		(2,272		)	(41		)
Income (Loss) Before Provision for Income Taxes		$	(489	)	$	6,364

 

Segment assets as of March 31, 2002 and December 31, 2001, are as follows:

 

		March 31, 2002			December 31, 2001
Assets
United States		$	81,940		$	81,736
International:
Latin America		24,029			25,402
Asia Pacific		19,093			20,424
Other		3,891			3,866
		$	128,953		$	131,428

 

9

 

Item 2.         MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF

OPERATIONS

 

The following discussion should be read in conjunction with the consolidated financial statements, the notes thereto and management’s discussion and analysis included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2001.

 

RESULTS OF OPERATIONS

 

The following table identifies (i) the relationship that net income items disclosed in the condensed consolidated financial statements have to total sales, and (ii) the amount and percent of change of such items compared to the corresponding prior period.

 

(Dollar Amounts in Thousands)

(Unaudited)

 

		(i)				(ii)
		Income and Expense Items as a Percent of Sales				Three Months Ended March 31 2002 to 2001
Income and		Three Months Ended March 31				Amount of Increase				Percent of
Expense Items		2002		2001		(Decrease)					Change
Sales		100.0	%	100.0	%	$	(5,834		)		(7.1	)%
Cost of goods sold		17.9		17.9		(998			)		(6.8	)
Volume incentives		44.0		44.4		(2,908			)		(8.0	)
SG&A expenses		35.7		29.9		2,694					11.0
Total operating expenses		97.6		92.2		(1,212			)		(1.6	)
Operating income		2.4		7.8		(4,622			)		(72.2	)
Other income, net		(3.0	)	—		(2,231			)		5,441.5
Income before provision for income taxes		(0.6	)	7.8		(6,853			)		(107.7	)
Provision for income taxes		0.6		2.9		(1,943			)		(83.0	)
Net income		(1.2	)%	4.9	%	$	(4,910		)		(122.1	)%

 

10

 

Sales Revenue

 

Sales revenue for the three months ended March 31, 2002, was $75.9 million compared to $81.7 million for the same period in the prior year, a decrease of approximately 7 percent.  The decrease in sales revenue for the three months ended March 31, 2002, reflects decreases in sales revenue in both the Company’s United States and international operations.

 

Sales revenue in the Company’s United States operation for the three months ended March 31, 2002, was $44.2 million, a decrease of approximately 3 percent compared to the same period in the prior year.  Increased product competition in the nutritional supplement market, as well as increased competition for Distributors caused the sales revenue decrease in the United States.  The Company expects competition to remain strong for the foreseeable future.

 

The Company’s international operations reported sales revenue of $31.7 million for the three months ended March 31, 2002, a decrease of approximately 11 percent compared to the same period in the prior year.

 

Sales revenue in Latin America was $15.8 million for the three months ended March 31, 2002, a decrease of 21 percent compared to the same period in the prior year.  The sales revenue decline experienced in Latin America was primarily due to import restrictions imposed by the Brazilian government, as well as a decrease in sales revenue reported by Venezuela related to devaluation in the local currency.

 

Sales revenue in Asia Pacific was $10.0 million for the three months ended March 31, 2002, a decrease of 2 percent compared to the same period in the prior year.  The sales revenue decline experienced in the Company’s Asia Pacific markets is the result of continued sales revenue decreases experienced in the Company’s Synergy operation.

 

Sales revenue in the Company’s other markets was $5.9 million for the three months ended March 31, 2002, an increase of 7 percent compared to the same period in the prior year.  The growth in sales revenue experienced in the Company’s other markets is primarily due to the results of its operations in the Russian Federation.

 

The Company’s independent sales force consists of Managers and Distributors.  A Distributor interested in earning additional income by committing more time and effort to selling the Company’s products may attain the rank of “Manager.”  Appointment as a Manager is dependent upon attaining certain purchase volume levels and demonstrating leadership abilities.  The number of Managers at March 31, 2002, was approximately 19,400 compared to approximately 18,000 at December 31, 2001.   The

 

11

 

number of Distributors at March 31, 2002, was approximately 570,000 compared to approximately 596,000 at December 31, 2001.

 

Cost of Goods Sold

 

For the three months ended March 31, 2002, cost of goods sold remained the same, as a percentage of sales, compared to the same period in the prior year.  Management expects cost of goods sold to remain relatively constant as a percent of sales during the remainder of 2002, compared to the three months ended March 31, 2002.

 

Volume Incentives

 

Volume incentives are payments to independent sales force members for reaching certain levels of sales revenue performance and organizational development and are an integral part of the Company’s direct sales marketing program.  Volume incentives vary slightly, on a percentage basis, by product due to the Company’s pricing policies.  For the three months ended March 31, 2002, the Company experienced a slight decrease in volume incentives, as a percentage of sales, compared to the same period the prior year. Management expects volume incentives to remain relatively constant, as a percent of sales, during the remainder of 2002, compared to the three months ended March 31, 2002.

 

Selling, General and Administrative

 

Selling, general and administrative expenses for the three months ended March 31, 2002, increased as a percent of sales compared to the same period of the prior year as a result of the decrease in sales revenue in the Company’s United States and international markets as well as expenditures associated with the Company’s sales conventions, travel and incentive programs.  During the quarter, the Company also had expenditures of $1.3 million associated with right-sizing its Brazilian and United States operations.  For the remainder of 2002, management expects selling, general and administrative expenses, as a percent of sales, to return to those levels as experienced in the prior year.

 

Other Income

 

Other income for the three months ended March 31, 2002, decreased approximately $2.2 million as a result of an impairment of the Company’s investment in Cetalon Corporation of $3.0 million.

 

Segment Information

 

See information included in the condensed consolidated financial statements under Item 1 Note 7.

 

12

 

Balance Sheet

 

Accrued Volume Incentives

 

Accrued volume incentives decreased approximately $.9 million as of March 31, 2002, compared to December 31, 2001, as a result of decreased U.S. and international sales revenue durng the quarter ended March 31, 2002.

 

Accrued Liabilities

 

Accrued liabilities increased approximately $2.3 million as of March 31, 2002, compared to December 31, 2001, as a result of accruals associated with the Company’s sales conventions, travel and incentive programs.

 

LIQUIDITY AND CAPITAL RESOURCES

 

Cash and cash equivalents increased approximately $.8 million as of March 31, 2002, compared to December 31, 2001.  The increase in cash and cash equivalents is primarily the result of operating income.  During the quarter ended March 31, 2002, the Company recorded an impairment loss of $3.0 million relating to long-term investments.  During the three months ended March 31, 2002, cash totaling $2.1 million was used to repurchase approximately 169,000 shares of common stock.

 

Management believes that working capital requirements can be met through the Company’s available cash and cash equivalents and internally-generated funds for the foreseeable future; however, a prolonged economic downturn or a decrease in the demand for the Company’s products could adversely affect the long-term liquidity of the Company.  In the event of a significant decrease in cash provided by the Company’s operating activities, it might be necessary for the Company to obtain external sources of funding.  The Company does not currently maintain a credit facility or any other external sources of long-term funding; however, management believes that such funding could be obtained on competitive terms.

 

Legal Proceedings

 

The Company is a defendant in various lawsuits which are incidental to the Company’s business.  Management, after consultation with legal counsel, believes that the ultimate disposition of these matters will not have a material effect upon the Company’s consolidated results of operations or financial position.

 

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations and other sections of this Form 10-Q may contain forward-looking statements.  Such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.  Such

 

13

 

statements may relate but not be limited to projections of revenues, income or loss, capital expenditures, plans for growth and future operations, financing needs, as well as assumptions relating to the foregoing.  Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified.  When used in “Management’s Discussion and Analysis of Financial Condition and Results of Operations”, and elsewhere in this Form 10-Q the words “estimates”, “expects”, “anticipates”, “projects”, “plans”, “intends” and variations of such words and similar expressions are intended to identify forward-looking statements that involve risks and uncertainties.  Future events and actual results could differ materially from those set forth in, contemplated by or underlying the forward-looking statements.

 

Item 3.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

The Company conducts its business in several countries and intends to continue to expand its foreign operations.  Sales revenue, operating income and net income are affected by fluctuations in currency exchange rates, interest rates and other uncertainties inherent in doing business and selling product in more than one currency.  In addition, the Company’s operations are exposed to risks associated with changes in social, political and economic conditions inherent in foreign operations, including changes in the laws and policies that govern foreign investment in countries where it has operations as well as, to a lesser extent, changes in United States laws and regulations relating to foreign trade and investment.

 

Foreign Currency Risk

 

During the three months ended March 31, 2002, approximately 42 percent of the Company’s revenue and expenses were realized outside of the United States.  Inventory purchases are transacted primarily in U.S. dollars from vendors located in the United States.  The local currency of each international subsidiary is considered the functional currency, and all sales and expenses are translated at average exchange rates for the reported periods.  Therefore, the Company’s sales revenue and expenses will be positively impacted by a weakening of the U.S. dollar and will be negatively impacted by a strengthening of the U.S. dollar.  Given the uncertainty of exchange rate fluctuations, the Company cannot estimate the affect of these fluctuations on the Company’s future business, product pricing, results of operations or financial condition.  Changes in currency exchange rates affect the relative prices at which the Company sells its products.  The Company regularly monitors its foreign currency risks and periodically takes measures to reduce the impact of foreign exchange rate fluctuations on the Company’s operating results.  The Company does not use derivative instruments for hedging, trading or speculating on foreign exchange rate fluctuations.

 

14

 

The following table sets forth average currency exchange rates of one U.S. dollar into local currency for each of the countries in which sales revenue exceeded $10.0 million during any of the previous two years.

 

Three Months Ended March 31		2002		2001
Brazil		2.4		2.0
Japan		132.5		118.1
Mexico		9.1		9.7
South Korea		1,315.8		1,270.6
Venezuela		856.9		702.2

 

Interest Rate Risk

 

The Company has investments, which by nature are subject to market risk.  At March 31, 2002, the Company had investments totaling $10.7 million of which $4.5 million were equity investments and $6.2 million were municipal obligations, which carry an average fixed interest rate of 5.2 percent and mature between one and five years.  A hypothetical one percent change in interest rates would not have a material affect on the Company’s liquidity, financial condition or results of operations.

 

PART II  OTHER INFORMATION

 

Item 6.  EXHIBITS AND REPORTS ON FORM 8-K

 

a)             No exhibits are required to be filed by Item 601 of Regulation S-K.

b)            No reports were filed on Form 8-K during the quarter for which this report is filed.

 

Other Items

 

There were no other items to be reported under Part II of this Report.

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

	NATURE’S SUNSHINE PRODUCTS, INC.
Date:  May 9, 2002	/s/ Daniel P. Howells
	Daniel P. Howells, President & Chief Executive Officer
Date:  May 9, 2002	/s/ Craig D. Huff
	Craig D. Huff, Chief Financial Officer

 

15